#WorldHepatitisDay @crick.ac.uk raising awareness by unifying #PublicHealth, #Clinical care, #DataScience, #Implementation & #LivedExperience. Aiming for #elimination. 🧪💪 #IDSky #HBV #NHS @ukhsa.bsky.social @cnwl.nhs.uk @nhsengland.bsky.social @worldhepalliance.bsky.social @ahri-news.bsky.social

HBV‑CARE 2026 is open for registration! On 8 Oct we’re gathering communicators, advocates, clinicians & researchers to rethink how we talk about emerging HBV treatments and decentralised, community‑centred care. Join us (Crick + online): www.eventbrite.fr/e/hbv-care-2... #HealthEquity #HBV

HBV-CARE 2026

HBV CARE 2026 will explore decentralised HBV care in an era of a changing treatment landscape.

eventbrite.fr

What an incredible day, so grateful to have been part of this! 🙏 The warmth and generosity of the Mongolian community at #Nadaam was truly special. Congrats @emilymartyn.bsky.social / @pippa-matt.bsky.social (MOLO project: wellcomeopenresearch.org/articles/11-... )! #HBV #WimbledonCommon #London

Philippa Matthews@pippa-matt.bsky.social · 2mo ago

A day of sunshine & hospitality at the #Nadaam festival at #WimbledonCommon #London today, talking about #hepatitis & #LiverHealth with the #Mongolian community, with art, food & music inspiring connections. ‘Liver screening changed my life’. #PublicEngagement #HBV @crick.ac.uk @uclh.bsky.social 🧪

Thrilled that our international team is funded by @wellcometrust.bsky.social for a 5 year project to develop insights into treatment delivery & outcomes tackling #HepatitisB #Elimination in #Africa. #CapeTown #AddisAbaba #Vestfold #HBV @crick.ac.uk @suhealthsci.bsky.social @bristoluni.bsky.social 🧪

The Francis Crick Institute@crick.ac.uk · 2mo ago

Group leader @pippa-matt.bsky.social and her team, the HBV Elimination Lab, are working with an international team of research groups to better understand the impact of scaling up hepatitis B treatment on African populations. https://bit.ly/4weLN4S

⏰ Abstract Deadline: TOMORROW (27th May)! Are you an ECR in infection science? Present your work at the 4th LINE (@londoninfectionecr.bsky.social) Symposium this June at the @crick.ac.uk, London! 🦠✨ #InfectionResearch #ScienceSky #ECR #AcademicSky #Microbiology

London Infection Network for/by ECRs (LINE)@londoninfectionecr.bsky.social · 3mo ago

Abstract deadline tomorrow! Don't miss it! 🤓

Don't miss out on registering for our symposium in June! There is still time to submit your abstracts for talks and posters! Submission deadline is 27th of May! Links below:

London Infection Network for/by ECRs (LINE)@londoninfectionecr.bsky.social · 6mo ago

📢NEWS:The 4th LINE symposium will be on June 22nd @TheCrick! Details:https://shorturl.at/LZPKT Join us for this day of ECR-led science, networking, brilliant invited speakers and a fantastic careers panel. Abstracts by May 10th:https://shorturl.at/UIXZg Free registration:https://shorturl.at/JRzzo

We're excited for our LINE+ seminar on Wednesday! It is not too late to register: tinyurl.com/2t56zfp8 We're sponsored by @nebiolabs.bsky.social and Twist! ...and the goodies have just arrived!

London Infection Network for/by ECRs (LINE)@londoninfectionecr.bsky.social · 4mo ago

📢 Our SECOND LINE+ seminar will be on May 20nd at Imperial College. @nthndy.bsky.social will join us to share how he turns his machine learning approaches to understand Mtb persistence into accessible interactive datasets. Registration/info: tinyurl.com/2t56zfp8 More about Nathan: nthndy.github.io

#WorldHepatitisSummit poster - our team shared #CommunityEngagement experience from our 'EVOLVE' #HBV project in #SouthAfrica to enhance interventions for #hepatitis #elimination. 🧪 👏 #WHS2026 #NoHep #MedSky #LiverSky @ahri-news.bsky.social @uclnews.bsky.social @crick.ac.uk doi.org/10.6084/m9.f...

📢NEWS:The 4th LINE symposium will be on June 22nd @TheCrick! Details:https://shorturl.at/LZPKT Join us for this day of ECR-led science, networking, brilliant invited speakers and a fantastic careers panel. Abstracts by May 10th:https://shorturl.at/UIXZg Free registration:https://shorturl.at/JRzzo

Thanks to everybody who made it to our seminar yesterday! We had two great talks by @safimicro.bsky.social and James Griffiths and a fantastic time at the social in the sun! More great events coming up soon...stay tuned! (A big thank you as always to our sponsors @nebiolabs.bsky.social and Twist.)

📢 Our SECOND LINE+ seminar will be on May 20nd at Imperial College. @nthndy.bsky.social will join us to share how he turns his machine learning approaches to understand Mtb persistence into accessible interactive datasets. Registration/info: tinyurl.com/2t56zfp8 More about Nathan: nthndy.github.io

Very proud to release this work! - huge collaboration to assess #HBV #epidemiology ( #infection & #immunity) in a large population study in #SouthAfrica. High prevalence, high #treatment need, low #vaccine mediated protection. @crick.ac.uk @uclnews.bsky.social @ahri-news.bsky.social 🧪 #MedSky

medRxivpreprint@medrxivpreprint.bsky.social · 5mo ago

EVOLVE-HBV: A retrospective cross-sectional study to quantify and characterise HBV infection, exposure, immunity and susceptibility in a rural population in KwaZulu-Natal, South Africa https://www.medrxiv.org/content/10.64898/2026.03.17.26347919v1

Brilliant that @emilymartyn.bsky.social is running the #LondonMarathon & fundraising for the #Museum of #Homelessness which tells stories & changes lives of people living with complex challenges. A privilege to support a cause close to my ❤️ @ourmoh.bsky.social www.justgiving.com/page/emily-m...

Emily's fundraiser for Museum of Homelessness

Help Emily Martyn raise money to support Museum of Homelessness

justgiving.com

Lots of focus on the impact of #funding cuts on #HIV but there are wider repercussions. Here we report 'Voices from the frontline: how global funding cuts are reshaping the viral #hepatitis response' 🧪 @lancetgastrohep.bsky.social @worldhepalliance.bsky.social www.thelancet.com/journals/lan...

Voices from the frontline: how global funding cuts are reshaping the viral hepatitis response

Hepatitis B virus (HBV) and hepatitis C virus (HCV) are among the world's leading infectious threats, together responsible for over a million deaths each year, but these infections remain neglected by...

thelancet.com

This week we hosted our first LINE+ seminar, with an inspirational talk from @sfauredupuy.bsky.social, bringing together science and impactful outreach! It was a great success! Thank you all for joining! We have already lined up a fantastic speaker for our second LINE+ this spring! Stay tuned!

Grateful to see Ana Puentes at @elpais.com spotlight our commentary on US funding cuts and their impact on viral hepatitis elimination. Visibility and public engagement are essential — especially right now. elpais.com/planeta-futu...

La lucha contra la hepatitis en África, en vilo por los recortes de EE UU: clínicas cerradas, menos pruebas e investigaciones canceladas

Hasta un 40% de las organizaciones han reportado “altos impactos” en su trabajo, según encuestas hechas por la Coalición para la Eliminación Global de la Hepatitis y otros grupos que alertan sobre el ...

elpais.com

Marion Delphin@mariondelphin.bsky.social · 6mo ago

Frontline evidence in collaboration with @globalhep.bsky.social and @worldhepalliance.bsky.social shows global funding cuts are already hitting viral hepatitis services. We can’t afford to reverse progress toward elimination. Protect hepatitis funding. Now. #Hepatitis #GlobalHealth

Frontline evidence in collaboration with @globalhep.bsky.social and @worldhepalliance.bsky.social shows global funding cuts are already hitting viral hepatitis services. We can’t afford to reverse progress toward elimination. Protect hepatitis funding. Now. #Hepatitis #GlobalHealth

Our preprint addresses therapeutic drug monitoring for #HBV #hepatitisB. It may sound niche, but is a huge clinical & research gap. Better understanding could inform better #treatment & improve outcomes. 🧪💊 #LiverSky #MedSky #IDSky #Pharmacology #TDM #tenofovir www.researchsquare.com/article/rs-8...

Absolute pleasure to welcome my very first mentor, @sfauredupuy.bsky.social, to kick off our very first LINE+ seminar series ✨ A scientist whose commitment to equity in science and access for all is as inspiring as her passion for viruses and macrophages 🦠💥 #LINE+ #EquityInSTEM #ScienceForAll

London Infection Network for/by ECRs (LINE)@londoninfectionecr.bsky.social · 7mo ago

📣NEWS📣: The first invited speaker in our new LINE+ seminar series is @sfauredupuy.bsky.social from Institut Cochin, Paris! Feb 18th at the Blizard Institute, hear all about her exciting research on viruses vs macrophages and science outreach! All welcome! Registration/details: tinyurl.com/3ys93ems

Our #liver #health project ‘MoLo’ for the #Mongolian Community in #London: #education, assessment for #diabetes, metabolic liver disease #MASLD, #HIV & viral #hepatitis, & linkage to care. Huge team effort with brilliant engagement. @who.int @crick.ac.uk @ucl.ac.uk #HBV #HCV #LiverSky #MedSky 🧪🇲🇳

#HepatitisC #HCV has been neglected in #Africa but affordable pangenotypic #DAA #treatment, community engagement & #decentralisation offer improved prospects. We report a #microelimination programme in #Uganda. @ndm.ox.ac.uk @crick.ac.uk @who.int 🧪🇺🇬🌍💊 #MedSky www.sciencedirect.com/science/arti...

Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: Long-term follow-up to assess feasibility and outcomes of a screening and treatment interventio...

The availability of highly effective curative direct acting antiviral (DAA) therapy for hepatitis C virus (HCV) is a cornerstone of elimination strate…

sciencedirect.com

Strengthening clinical, translational, implementation #research in #Africa for the #elimination of viral #hepatitis is an urgent #PublicHealth priority. We have the tools, but the field has been neglected. 🧪 #HBV #MedSky @lancetmicrobe.bsky.social @who.int www.sciencedirect.com/science/arti...

Strengthening hepatitis B virus clinical research in Africa: the need for multistakeholder collaboration, funding, and political will

Africa bears a disproportionate burden of hepatitis B virus (HBV) infection, with 68 million chronically infected individuals and 65% of global new in…

sciencedirect.com

We describe #HBV infection in #Uganda, to determine #treatment eligibility. #Liver assessment by #fibroscan important to determine who should be treated. Some drug resistance motifs seen in the context of #HIV. @who.int @crick.ac.uk @ndm.ox.ac.uk #LSHTM #UVRI #MedSky 🇺🇬 🧪 doi.org/10.1016/j.ji...

And here's to another year of ECRs networking! I am so glad of what we achieved this year, and i cannot wait for the new adventures ahead. #ECRs #LondonInfection #UKinfectiondiseaseresearch #LINE

London Infection Network for/by ECRs (LINE)@londoninfectionecr.bsky.social · 8mo ago

Hope you all have an amazing break filled with good food and great company! ✨ As we wrap up 2025, we're excited to announce our 4th annual celebration of ECR-led infection research: 📢Save the Date: LINE Symposium 2026 📅Monday June 22nd 2026 📍 Francis Crick Institute More details coming in 2026!

Make the wrong decisions for #vaccines & ‘preventable diseases can come roaring back’. A timely dose of #HBV vaccine at birth is one of our simplest, safest & best anti #cancer strategies. Universal access matters. Look at the figure below- a stunning success since roll-out. @gavi.org #MedSky 🧪

Tara Haelle@tarahaelle.bsky.social · 9mo ago

A great overview on what to expect from the CDC vaccine meeting tomorrow and Friday. Pay special attention to the playbook at the end — every single one of those tactics is likely to be used and is easily recognizable if you know what to look for. yourlocalepidemiologist.substack.com/p/what-to-ex...

I was really proud to be part of the #MoLo project this weekend. The #communityengagement was incredible, it was a powerful and inspiring example of how clinical care and multidisciplinary research can come together to make a real impact - huge congrats to @emilymartyn.bsky.social!

Philippa Matthews@pippa-matt.bsky.social · 9mo ago

Project 'MoLo' for #Mongolians in #London offering education & screening focusing on #liver & #metabolic health & viral #hepatitis - fantastic community uptake. #MedSky #LiverSky #PublicHealth #Mongolia #NHS #NoHep #InclusionHealth #HBV @emilymartyn.bsky.social @crick.ac.uk @uclnews.bsky.social 🧪🇲🇳

📢📢📢 Our next LINE seminar is approaching. This time with a twist: On Wed the 26th of Nov, we will be meeting in Cambridge @mrclmb.bsky.social! Sina Krokowski and @juliasg.bsky.social will be sharing their science! All info and registration to join in person or online here: tinyurl.com/LINEseminar

#HBV #CDC #NIHfundingcuts

Philippa Matthews@pippa-matt.bsky.social · 11mo ago

📢 Call to anyone working in - or affected by - #HIV #HBV #hepatitis, as we gather data about impact of #funding cuts. Can you help with a short questionnaire? link here ⬇️ forms.gle/nUJZFpMTdiwB... Can be anonymous. Preliminary results in this thread. #PEPFAR #CDC #NIH #MedSky #LiverSky #NoHep 🧪

Work presented at the international #HBV meeting & #COLDA highlights high level impact & profound concern around loss of funding for #hepatitis clinical care, public health programmes & research. 🧪 @crick.ac.uk @mariondelphin.bsky.social @worldhepalliance.bsky.social doi.org/10.6084/m9.f...

Shout out to @lou-downs.bsky.social & Dorcas Okanda for a prize at #COLDA. Their #HBV work in #Kenya expands insights in a neglected space, using #virus #genomics to influence healthcare. #MedSky #NoHep @crick.ac.uk @ndm.ox.ac.uk @ucl.ac.uk @wellcometrust.bsky.social @kemriwellcome.bsky.social 🧪🇰🇪🌍